Sign In
Buy VKTX
$31.74
-1.37 (-4.14%)
At Close: Jul 31, 2026
VKTX Q2 Earnings Beat Estimates Despite Surge in R&D Costs
01:35pm, Thursday, 30'th Jul 2026
Viking Therapeutics beats second-quarter loss estimates as it advances late-stage obesity studies despite sharply higher R&D spending tied to its expanding pipeline.
Viking Therapeutics, Inc. (VKTX) Q2 2026 Earnings Call Transcript
10:53pm, Wednesday, 29'th Jul 2026
Viking Therapeutics, Inc. (VKTX) Q2 2026 Earnings Call Transcript
Viking Therapeutics Q2 Earnings Call Highlights
09:04pm, Wednesday, 29'th Jul 2026
Viking Therapeutics NASDAQ: VKTX reported a wider second-quarter loss as the company increased spending to advance its obesity pipeline, including its lead dual GLP-1/GIP receptor agonist, VK2735, thr
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
04:05pm, Wednesday, 29'th Jul 2026
Conference call scheduled for 4:30 p.m. ET today -- Phase 3 VANQUISH 1 & 2 Trials for Subcutaneous VK2735 in Obesity Fully Enrolled and Advancing -- -- Oral Phase 3 VK2735 Trial Initiation Expected 4Q
3 Biotech Stocks With Massive Upside to Buy Before August Starts
08:00am, Wednesday, 29'th Jul 2026
Biotech is setting up as one of the more interesting risk-on trades heading into the back half of 2026.
Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case
05:00pm, Tuesday, 28'th Jul 2026
Viking Therapeutics has a promising pipeline candidate in late-stage studies. Positive results from ongoing phase 3 trials could send the stock soaring.
Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?
11:10am, Tuesday, 28'th Jul 2026
Biotech earnings take center stage as Viking, Biogen, Bristol Myers, Regeneron and AbbVie prepare to report Q2 2026 results.
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Tuesday, 28'th Jul 2026
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
06:46pm, Thursday, 23'rd Jul 2026
Viking Therapeutics, Inc. (VKTX) reached $35.39 at the closing of the latest trading day, reflecting a -5.15% change compared to its last close.
Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors
07:05am, Thursday, 23'rd Jul 2026
Experienced Executive Brings Over Two Decades of Leadership Across Healthcare, Digital Health and Commercialization SAN DIEGO,, July 23, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
04:05pm, Wednesday, 22'nd Jul 2026
Conference Call Scheduled for Wednesday, July 29, at 4:30 p.m. Eastern Time SAN DIEGO, July 22, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmac
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm
04:41pm, Tuesday, 21'st Jul 2026
NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Viking Therapeutics, Inc. (NASDAQ: VKTX) breach
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
03:45pm, Saturday, 18'th Jul 2026
Viking Therapeutics just launched its next-gen weight loss program. Novo Nordisk and Eli Lilly are already deep into the development process with comparable programs.
Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes.
09:30am, Saturday, 18'th Jul 2026
The key trial results for VK2735 are still years away. There are some useful indicative results coming from a phase 1 maintenance trial over the next six or so months.
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
06:46pm, Friday, 17'th Jul 2026
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $37.08, representing a +1.95% change from its previous close.
